[{"edinetCode":"E00836","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":5517.0,"averageTemporaryStaff":822.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":77344000.0,"sharesOwendPercent":0.4237,"outstandingShares":null,"numberOfSubsidiary":27.0,"bps":1120.73,"equityRatio":0.711,"cashAndCashEquivalents":51785000000.0,"assets":272791000000.0,"currentAssets":153602000000.0,"fixedAsset":119100000000.0,"tangibleFixedAssets":80230000000.0,"intangibleFixedAssets":2375000000.0,"investmentAndOtherAssets":36494000000.0,"liabilities":66924000000.0,"currentLiabilities":41321000000.0,"shorTermDept":6306000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":25603000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":8201000000.0,"netAsset":205866000000.0,"capitalStock":184664000000.0,"capital":14932000000.0,"capitalSurplus":17587000000.0,"accumulatedEarnings":162615000000.0,"treasuryStock":-10471000000.0,"valuationAndConversionAdjustments":9397000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":159117000000.0,"costOfSales":95253000000.0,"grossProfit":63864000000.0,"sgaExpenses":44213000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":19646000000.0,"nonOperatingIncome":2060000000.0,"nonOperatingExpenses":1759000000.0,"interestExpense":132000000.0,"ordinaryProfit":19947000000.0,"extraordinaryGain":3160000000.0,"extraordinaryLoss":710000000.0,"incomeBeforeTax":22397000000.0,"incomeTaxes":6020000000.0,"netIncome":16377000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":15635000000.0,"comprehensiveIncome":13668000000.0,"eps":90.23,"dilutedEps":90.21,"dividendPerShare":null,"per":16.7,"roe":0.082,"cashFlowFromOperatingActivities":31390000000.0,"depreciationAndCashflowFromOperatingActivities":11343000000.0,"cashFlowFromInvestingActivities":-11913000000.0,"cashFlowFromFinancialActivities":-14103000000.0,"changesInCashAndCashEquivalents":4320000000.0,"列1":"asr","submitDate":"2017\/6\/28","stockCode":4272,"accountingYear":"第160期(自　平成28年４月１日　至　平成29年３月31日)","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":5684.0,"averageTemporaryStaff":761.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":80252000.0,"sharesOwendPercent":0.463,"outstandingShares":null,"numberOfSubsidiary":29.0,"bps":1203.12,"equityRatio":0.724,"cashAndCashEquivalents":50532000000.0,"assets":287565000000.0,"currentAssets":160312000000.0,"fixedAsset":127194000000.0,"tangibleFixedAssets":83228000000.0,"intangibleFixedAssets":3436000000.0,"investmentAndOtherAssets":40529000000.0,"liabilities":66962000000.0,"currentLiabilities":42746000000.0,"shorTermDept":6714000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":24215000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":7577000000.0,"netAsset":220602000000.0,"capitalStock":194501000000.0,"capital":14932000000.0,"capitalSurplus":17596000000.0,"accumulatedEarnings":172460000000.0,"treasuryStock":-10489000000.0,"valuationAndConversionAdjustments":13814000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":167888000000.0,"costOfSales":102475000000.0,"grossProfit":65413000000.0,"sgaExpenses":42800000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":22606000000.0,"nonOperatingIncome":1912000000.0,"nonOperatingExpenses":2048000000.0,"interestExpense":161000000.0,"ordinaryProfit":22471000000.0,"extraordinaryGain":2000000.0,"extraordinaryLoss":421000000.0,"incomeBeforeTax":22052000000.0,"incomeTaxes":5854000000.0,"netIncome":16198000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":15472000000.0,"comprehensiveIncome":20540000000.0,"eps":89.36,"dilutedEps":89.35,"dividendPerShare":null,"per":14.6,"roe":0.077,"cashFlowFromOperatingActivities":20121000000.0,"depreciationAndCashflowFromOperatingActivities":11656000000.0,"cashFlowFromInvestingActivities":-16171000000.0,"cashFlowFromFinancialActivities":-6241000000.0,"changesInCashAndCashEquivalents":-1252000000.0,"列1":"asr","submitDate":"2018\/6\/27","stockCode":4272,"accountingYear":"第161期(自　2017年４月１日　至　2018年３月31日)","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":5814.0,"averageTemporaryStaff":701.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":83234000.0,"sharesOwendPercent":0.4807,"outstandingShares":null,"numberOfSubsidiary":27.0,"bps":1247.75,"equityRatio":0.736,"cashAndCashEquivalents":52697000000.0,"assets":293571000000.0,"currentAssets":161958000000.0,"fixedAsset":131592000000.0,"tangibleFixedAssets":87246000000.0,"intangibleFixedAssets":3493000000.0,"investmentAndOtherAssets":40852000000.0,"liabilities":64528000000.0,"currentLiabilities":41412000000.0,"shorTermDept":5472000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":23116000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":8778000000.0,"netAsset":229043000000.0,"capitalStock":204171000000.0,"capital":14932000000.0,"capitalSurplus":17596000000.0,"accumulatedEarnings":182133000000.0,"treasuryStock":-10490000000.0,"valuationAndConversionAdjustments":11869000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":172639000000.0,"costOfSales":109461000000.0,"grossProfit":63177000000.0,"sgaExpenses":43238000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":19939000000.0,"nonOperatingIncome":2317000000.0,"nonOperatingExpenses":649000000.0,"interestExpense":194000000.0,"ordinaryProfit":21608000000.0,"extraordinaryGain":361000000.0,"extraordinaryLoss":686000000.0,"incomeBeforeTax":21283000000.0,"incomeTaxes":5602000000.0,"netIncome":15681000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":14851000000.0,"comprehensiveIncome":13788000000.0,"eps":85.77,"dilutedEps":85.75,"dividendPerShare":null,"per":15.2,"roe":0.07,"cashFlowFromOperatingActivities":26803000000.0,"depreciationAndCashflowFromOperatingActivities":11969000000.0,"cashFlowFromInvestingActivities":-17694000000.0,"cashFlowFromFinancialActivities":-6437000000.0,"changesInCashAndCashEquivalents":2165000000.0,"列1":"asr","submitDate":"2019\/6\/25","stockCode":4272,"accountingYear":"第162期(自　2018年４月１日　至　2019年３月31日)","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.742,"cashAndCashEquivalents":null,"assets":287848000000.0,"currentAssets":158618000000.0,"fixedAsset":129218000000.0,"tangibleFixedAssets":87019000000.0,"intangibleFixedAssets":3486000000.0,"investmentAndOtherAssets":38711000000.0,"liabilities":61394000000.0,"currentLiabilities":39634000000.0,"shorTermDept":5432000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":21760000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":7689000000.0,"netAsset":226453000000.0,"capitalStock":204696000000.0,"capital":14932000000.0,"capitalSurplus":17588000000.0,"accumulatedEarnings":177059000000.0,"treasuryStock":-4884000000.0,"valuationAndConversionAdjustments":8996000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":42893000000.0,"costOfSales":28057000000.0,"grossProfit":14836000000.0,"sgaExpenses":10092000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":4744000000.0,"nonOperatingIncome":812000000.0,"nonOperatingExpenses":961000000.0,"interestExpense":73000000.0,"ordinaryProfit":4595000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":166000000.0,"incomeBeforeTax":4428000000.0,"incomeTaxes":1263000000.0,"netIncome":3165000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3122000000.0,"comprehensiveIncome":120000000.0,"eps":18.03,"dilutedEps":18.03,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":4272,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":82950000.0,"sharesOwendPercent":0.479,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.75,"cashAndCashEquivalents":51297000000.0,"assets":287017000000.0,"currentAssets":156442000000.0,"fixedAsset":130571000000.0,"tangibleFixedAssets":87487000000.0,"intangibleFixedAssets":3322000000.0,"investmentAndOtherAssets":39761000000.0,"liabilities":58923000000.0,"currentLiabilities":38807000000.0,"shorTermDept":5187000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":20115000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6600000000.0,"netAsset":228093000000.0,"capitalStock":207912000000.0,"capital":14932000000.0,"capitalSurplus":17589000000.0,"accumulatedEarnings":180274000000.0,"treasuryStock":-4884000000.0,"valuationAndConversionAdjustments":7457000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":85608000000.0,"costOfSales":56325000000.0,"grossProfit":29282000000.0,"sgaExpenses":20236000000.0,"salaryAndBenefit":null,"depreciationAndSGA":210000000.0,"RDExpenses":5371000000.0,"operatingIncome":9045000000.0,"nonOperatingIncome":1147000000.0,"nonOperatingExpenses":1044000000.0,"interestExpense":87000000.0,"ordinaryProfit":9149000000.0,"extraordinaryGain":33000000.0,"extraordinaryLoss":341000000.0,"incomeBeforeTax":8840000000.0,"incomeTaxes":2438000000.0,"netIncome":6402000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":6337000000.0,"comprehensiveIncome":1760000000.0,"eps":36.6,"dilutedEps":36.59,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":15746000000.0,"depreciationAndCashflowFromOperatingActivities":5983000000.0,"cashFlowFromInvestingActivities":-10450000000.0,"cashFlowFromFinancialActivities":-5167000000.0,"changesInCashAndCashEquivalents":-1400000000.0,"列1":"q2r","submitDate":"2019\/11\/13","stockCode":4272,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.719,"cashAndCashEquivalents":null,"assets":302680000000.0,"currentAssets":168398000000.0,"fixedAsset":134281000000.0,"tangibleFixedAssets":89193000000.0,"intangibleFixedAssets":3327000000.0,"investmentAndOtherAssets":41760000000.0,"liabilities":84237000000.0,"currentLiabilities":51405000000.0,"shorTermDept":14053000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":32831000000.0,"bonds":12000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6562000000.0,"netAsset":218443000000.0,"capitalStock":207149000000.0,"capital":14932000000.0,"capitalSurplus":15715000000.0,"accumulatedEarnings":182642000000.0,"treasuryStock":-6141000000.0,"valuationAndConversionAdjustments":10595000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":131825000000.0,"costOfSales":87160000000.0,"grossProfit":44664000000.0,"sgaExpenses":30433000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":14231000000.0,"nonOperatingIncome":1618000000.0,"nonOperatingExpenses":1166000000.0,"interestExpense":152000000.0,"ordinaryProfit":14682000000.0,"extraordinaryGain":376000000.0,"extraordinaryLoss":481000000.0,"incomeBeforeTax":14578000000.0,"incomeTaxes":3223000000.0,"netIncome":11354000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":11302000000.0,"comprehensiveIncome":9875000000.0,"eps":65.33,"dilutedEps":65.3,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/13","stockCode":4272,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":5847.0,"averageTemporaryStaff":732.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":82681000.0,"sharesOwendPercent":0.484,"outstandingShares":null,"numberOfSubsidiary":27.0,"bps":1225.71,"equityRatio":0.752,"cashAndCashEquivalents":46663000000.0,"assets":278496000000.0,"currentAssets":153102000000.0,"fixedAsset":125393000000.0,"tangibleFixedAssets":85960000000.0,"intangibleFixedAssets":3362000000.0,"investmentAndOtherAssets":36071000000.0,"liabilities":68477000000.0,"currentLiabilities":38800000000.0,"shorTermDept":4359000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":29676000000.0,"bonds":12000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6182000000.0,"netAsset":210019000000.0,"capitalStock":206975000000.0,"capital":14932000000.0,"capitalSurplus":15757000000.0,"accumulatedEarnings":184156000000.0,"treasuryStock":-7871000000.0,"valuationAndConversionAdjustments":2369000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":175123000000.0,"costOfSales":117059000000.0,"grossProfit":58063000000.0,"sgaExpenses":40587000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":17485000000.0,"nonOperatingIncome":1836000000.0,"nonOperatingExpenses":1295000000.0,"interestExpense":165000000.0,"ordinaryProfit":18026000000.0,"extraordinaryGain":1069000000.0,"extraordinaryLoss":954000000.0,"incomeBeforeTax":18141000000.0,"incomeTaxes":5262000000.0,"netIncome":12879000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":12815000000.0,"comprehensiveIncome":3157000000.0,"eps":74.25,"dilutedEps":74.23,"dividendPerShare":null,"per":13.4,"roe":0.06,"cashFlowFromOperatingActivities":27281000000.0,"depreciationAndCashflowFromOperatingActivities":12384000000.0,"cashFlowFromInvestingActivities":-17543000000.0,"cashFlowFromFinancialActivities":-13894000000.0,"changesInCashAndCashEquivalents":-6034000000.0,"列1":"asr","submitDate":"2020\/6\/25","stockCode":4272,"accountingYear":"第163期(自　2019年４月１日　至　2020年３月31日)","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.735,"cashAndCashEquivalents":null,"assets":287373000000.0,"currentAssets":153155000000.0,"fixedAsset":134217000000.0,"tangibleFixedAssets":87091000000.0,"intangibleFixedAssets":8144000000.0,"investmentAndOtherAssets":38980000000.0,"liabilities":75596000000.0,"currentLiabilities":45278000000.0,"shorTermDept":13888000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":30318000000.0,"bonds":12000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":6129000000.0,"netAsset":211776000000.0,"capitalStock":206161000000.0,"capital":14932000000.0,"capitalSurplus":15757000000.0,"accumulatedEarnings":183342000000.0,"treasuryStock":-7871000000.0,"valuationAndConversionAdjustments":4951000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":36825000000.0,"costOfSales":24676000000.0,"grossProfit":12148000000.0,"sgaExpenses":9375000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2773000000.0,"nonOperatingIncome":618000000.0,"nonOperatingExpenses":407000000.0,"interestExpense":50000000.0,"ordinaryProfit":2984000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":104000000.0,"incomeBeforeTax":2879000000.0,"incomeTaxes":1131000000.0,"netIncome":1748000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1748000000.0,"comprehensiveIncome":4326000000.0,"eps":10.24,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/7","stockCode":4272,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":83037000.0,"sharesOwendPercent":0.4862,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.739,"cashAndCashEquivalents":51739000000.0,"assets":290607000000.0,"currentAssets":155623000000.0,"fixedAsset":134984000000.0,"tangibleFixedAssets":88173000000.0,"intangibleFixedAssets":7913000000.0,"investmentAndOtherAssets":38897000000.0,"liabilities":75121000000.0,"currentLiabilities":45796000000.0,"shorTermDept":13822000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":29325000000.0,"bonds":12000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":4972000000.0,"netAsset":215485000000.0,"capitalStock":209295000000.0,"capital":14932000000.0,"capitalSurplus":15757000000.0,"accumulatedEarnings":186477000000.0,"treasuryStock":-7872000000.0,"valuationAndConversionAdjustments":5517000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":80518000000.0,"costOfSales":54537000000.0,"grossProfit":25981000000.0,"sgaExpenses":19004000000.0,"salaryAndBenefit":null,"depreciationAndSGA":304000000.0,"RDExpenses":5318000000.0,"operatingIncome":6976000000.0,"nonOperatingIncome":1102000000.0,"nonOperatingExpenses":737000000.0,"interestExpense":59000000.0,"ordinaryProfit":7341000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":232000000.0,"incomeBeforeTax":7108000000.0,"incomeTaxes":2226000000.0,"netIncome":4882000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":4883000000.0,"comprehensiveIncome":8035000000.0,"eps":28.59,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":11879000000.0,"depreciationAndCashflowFromOperatingActivities":6019000000.0,"cashFlowFromInvestingActivities":-12762000000.0,"cashFlowFromFinancialActivities":5677000000.0,"changesInCashAndCashEquivalents":5076000000.0,"列1":"q2r","submitDate":"2020\/11\/12","stockCode":4272,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.757,"cashAndCashEquivalents":null,"assets":288456000000.0,"currentAssets":154376000000.0,"fixedAsset":134079000000.0,"tangibleFixedAssets":88387000000.0,"intangibleFixedAssets":7155000000.0,"investmentAndOtherAssets":38536000000.0,"liabilities":69288000000.0,"currentLiabilities":39690000000.0,"shorTermDept":3688000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":29597000000.0,"bonds":12000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":4931000000.0,"netAsset":219167000000.0,"capitalStock":210820000000.0,"capital":14932000000.0,"capitalSurplus":15756000000.0,"accumulatedEarnings":188004000000.0,"treasuryStock":-7872000000.0,"valuationAndConversionAdjustments":7650000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":125655000000.0,"costOfSales":84992000000.0,"grossProfit":40663000000.0,"sgaExpenses":28873000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":11790000000.0,"nonOperatingIncome":1650000000.0,"nonOperatingExpenses":1295000000.0,"interestExpense":110000000.0,"ordinaryProfit":12145000000.0,"extraordinaryGain":926000000.0,"extraordinaryLoss":319000000.0,"incomeBeforeTax":12752000000.0,"incomeTaxes":3773000000.0,"netIncome":8979000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":8971000000.0,"comprehensiveIncome":14274000000.0,"eps":52.53,"dilutedEps":52.53,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/10","stockCode":4272,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":5664.0,"averageTemporaryStaff":717.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":74851000.0,"sharesOwendPercent":0.4384,"outstandingShares":null,"numberOfSubsidiary":26.0,"bps":1332.06,"equityRatio":0.772,"cashAndCashEquivalents":47483000000.0,"assets":294535000000.0,"currentAssets":156852000000.0,"fixedAsset":137683000000.0,"tangibleFixedAssets":88980000000.0,"intangibleFixedAssets":6837000000.0,"investmentAndOtherAssets":41864000000.0,"liabilities":66261000000.0,"currentLiabilities":37491000000.0,"shorTermDept":3632000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":28769000000.0,"bonds":12000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":3770000000.0,"netAsset":228273000000.0,"capitalStock":214420000000.0,"capital":14932000000.0,"capitalSurplus":15754000000.0,"accumulatedEarnings":191606000000.0,"treasuryStock":-7872000000.0,"valuationAndConversionAdjustments":13085000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":173381000000.0,"costOfSales":117067000000.0,"grossProfit":56314000000.0,"sgaExpenses":41124000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":15194000000.0,"nonOperatingIncome":2034000000.0,"nonOperatingExpenses":689000000.0,"interestExpense":105000000.0,"ordinaryProfit":16538000000.0,"extraordinaryGain":1819000000.0,"extraordinaryLoss":835000000.0,"incomeBeforeTax":17523000000.0,"incomeTaxes":4932000000.0,"netIncome":12590000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":12574000000.0,"comprehensiveIncome":23368000000.0,"eps":73.62,"dilutedEps":73.61,"dividendPerShare":null,"per":14.5,"roe":0.058,"cashFlowFromOperatingActivities":24408000000.0,"depreciationAndCashflowFromOperatingActivities":12810000000.0,"cashFlowFromInvestingActivities":-17606000000.0,"cashFlowFromFinancialActivities":-8402000000.0,"changesInCashAndCashEquivalents":820000000.0,"列1":"asr","submitDate":"2021\/6\/25","stockCode":4272,"accountingYear":"第164期(自　2020年４月１日　至　2021年３月31日)","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.773,"cashAndCashEquivalents":null,"assets":297619000000.0,"currentAssets":159228000000.0,"fixedAsset":138390000000.0,"tangibleFixedAssets":88414000000.0,"intangibleFixedAssets":8069000000.0,"investmentAndOtherAssets":41907000000.0,"liabilities":66807000000.0,"currentLiabilities":37317000000.0,"shorTermDept":3724000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":29490000000.0,"bonds":12000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":3751000000.0,"netAsset":230812000000.0,"capitalStock":216339000000.0,"capital":14932000000.0,"capitalSurplus":15759000000.0,"accumulatedEarnings":194351000000.0,"treasuryStock":-8704000000.0,"valuationAndConversionAdjustments":13689000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":46447000000.0,"costOfSales":30319000000.0,"grossProfit":16128000000.0,"sgaExpenses":10189000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":5938000000.0,"nonOperatingIncome":796000000.0,"nonOperatingExpenses":335000000.0,"interestExpense":28000000.0,"ordinaryProfit":6399000000.0,"extraordinaryGain":1371000000.0,"extraordinaryLoss":115000000.0,"incomeBeforeTax":7655000000.0,"incomeTaxes":2346000000.0,"netIncome":5309000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5295000000.0,"comprehensiveIncome":5923000000.0,"eps":31.05,"dilutedEps":31.05,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/6","stockCode":4272,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":80074000.0,"sharesOwendPercent":0.4759,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.77,"cashAndCashEquivalents":50410000000.0,"assets":301957000000.0,"currentAssets":162518000000.0,"fixedAsset":139438000000.0,"tangibleFixedAssets":87527000000.0,"intangibleFixedAssets":7911000000.0,"investmentAndOtherAssets":44000000000.0,"liabilities":68497000000.0,"currentLiabilities":40030000000.0,"shorTermDept":4103000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":28466000000.0,"bonds":12000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":2621000000.0,"netAsset":233460000000.0,"capitalStock":218183000000.0,"capital":14932000000.0,"capitalSurplus":15765000000.0,"accumulatedEarnings":198256000000.0,"treasuryStock":-10771000000.0,"valuationAndConversionAdjustments":14469000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":88840000000.0,"costOfSales":57622000000.0,"grossProfit":31218000000.0,"sgaExpenses":20315000000.0,"salaryAndBenefit":null,"depreciationAndSGA":365000000.0,"RDExpenses":5848000000.0,"operatingIncome":10902000000.0,"nonOperatingIncome":1249000000.0,"nonOperatingExpenses":323000000.0,"interestExpense":39000000.0,"ordinaryProfit":11828000000.0,"extraordinaryGain":1453000000.0,"extraordinaryLoss":309000000.0,"incomeBeforeTax":12972000000.0,"incomeTaxes":3720000000.0,"netIncome":9251000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":9205000000.0,"comprehensiveIncome":10655000000.0,"eps":54.27,"dilutedEps":54.26,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":14384000000.0,"depreciationAndCashflowFromOperatingActivities":6631000000.0,"cashFlowFromInvestingActivities":-5573000000.0,"cashFlowFromFinancialActivities":-6397000000.0,"changesInCashAndCashEquivalents":2926000000.0,"列1":"q2r","submitDate":"2021\/11\/11","stockCode":4272,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0},{"edinetCode":"E00836","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.766,"cashAndCashEquivalents":null,"assets":309637000000.0,"currentAssets":170879000000.0,"fixedAsset":138757000000.0,"tangibleFixedAssets":87488000000.0,"intangibleFixedAssets":7647000000.0,"investmentAndOtherAssets":43622000000.0,"liabilities":71608000000.0,"currentLiabilities":46319000000.0,"shorTermDept":3504000000.0,"currentPortionOfBonds":4000000000.0,"currentPortionOfLongTermDebt":null,"fixedLiabilities":25288000000.0,"bonds":8000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":2596000000.0,"netAsset":238029000000.0,"capitalStock":220517000000.0,"capital":14932000000.0,"capitalSurplus":15770000000.0,"accumulatedEarnings":200586000000.0,"treasuryStock":-10771000000.0,"valuationAndConversionAdjustments":16661000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":138095000000.0,"costOfSales":89883000000.0,"grossProfit":48211000000.0,"sgaExpenses":30871000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":17339000000.0,"nonOperatingIncome":1761000000.0,"nonOperatingExpenses":319000000.0,"interestExpense":77000000.0,"ordinaryProfit":18781000000.0,"extraordinaryGain":1575000000.0,"extraordinaryLoss":503000000.0,"incomeBeforeTax":19854000000.0,"incomeTaxes":5740000000.0,"netIncome":14114000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":14058000000.0,"comprehensiveIncome":17743000000.0,"eps":83.1,"dilutedEps":83.09,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/10","stockCode":4272,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00836","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":14932,"settlementDate":"2022\/3\/31","submitterName":"日本化薬株式会社","submitterNameEnglish":"NIPPON KAYAKU CO.,LTD.","submitterNameKana":"ニホンカヤクカブシキガイシャ","location":"千代田区丸の内二丁目１番１号","industory":"化学","corporateNumber":3010000000000.0}]